AULBIO
Latest round
- Series C
Last raised
- Dec 2025
Total raised
- $14M
Investors
- 7
About AULBIO
Founded in 2018 and based in Seongnam, South Korea, AULBIO is a biotechnology research company specializing in research, development, and commercialization of formulated brand products based on drug delivery technology. The firm develops and commercializes long-acting biopharmaceuticals using its proprietary microsphere platform technology based on its drug delivery technology (DDS). The firm offers long-acting injectable microspheres based on biodegradable microspheres containing peptide drugs that reduce the number of daily injections to monthly injections for conditions like diabetes, obesity, and prostate cancer.
Who invested in AULBIO
7 investors across 2 rounds
See all investors in AULBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AULBIO
Who invested in AULBIO?
AULBIO has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AULBIO raised?
AULBIO has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AULBIO last raise money?
AULBIO's most recent round on record is a Series C, in Dec 2025.
What does AULBIO do?
Founded in 2018 and based in Seongnam, South Korea, AULBIO is a biotechnology research company specializing in research, development, and commercialization of formulated brand products based on drug delivery technology.
Where is AULBIO headquartered?
AULBIO is headquartered in Seongnam-si, South Korea.
Which VCs invest in companies like AULBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at AULBIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like AULBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.